/
/
GliMR members join forces in writing 3 reviews

GliMR members join forces in writing 3 reviews

Update on the 3 GliMR reviews
Share:
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
WhatsApp Image 2020-05-25 at 14.46.17

In April, WG1 and WG3 launched an invitation for all GliMR-members to collaborate with the preparation of one of our three reviews. With more than 40 contributors, this call was a huge success.

Most members chose the review on ‘Advanced MR techniques for glioma characterisation’ as first choice, followed by the review ‘MR Biomarkers for assessing the treatment follow-up’, and finally the review ‘Adverse effects of treatment on the healthy brain tissue’. All members were then contacted, and finally 28, 10 and 5 members signed up for the three reviews, respectively.

This questionnaire also provided some insights on the experience of the responding members. Regarding MRI-techniques, most members are experienced in diffusion, DSC/DCE, spectroscopy, CEST and radiomics, followed by ASL, fMRI and SWI. Additionally, a high experience was noted in the fields of neuro-oncology and clinical neuroradiology.

Currently, the development of the first review has started, while reviews two and three are still in preparation.

Recent News

Do you want to use machine learning to improve brain tumor imaging? Your challenge You will explore whether MRI diagnostics in brain tumor (glioma) patients can be performed without using the commonly used contrast agent gadolinium but instead using...

Abstract Submission PPT incl QR Code

Submit your abstract for ESMRMB 2021! The deadline is extended to June 8th, 2021. More information can be found on the ESMRMB website. Make sure you use the proper COST and GliMR acknowledgements. This is one of the requirements...

Congratulations to our Researcher of the Month: Patrick Tang Don’t forget to nominate one of our colleagues for researcher of the month! Patrick Tang Patrick is a MSc student Technical Medicine at the Erasmus Medical Center in the Netherlands....